Skip to main content
Clinical Trials/NCT05493579
NCT05493579
Completed
N/A

"Impact of Mandibular Implant Supported Overdenture on Changes of Electromyographic Activity, Brain Activity, Cognitive Function, Nutrition and Depression Status."

Al-Azhar University1 site in 1 country10 target enrollmentOctober 1, 2020

Overview

Phase
N/A
Intervention
Not specified
Conditions
Implant Supported Overdenture
Sponsor
Al-Azhar University
Enrollment
10
Locations
1
Primary Endpoint
Brain Activity (EEG)
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

The purpose of this study is to evaluate and compare the effects of a mandibular implant-supported overdenture with a mandibular complete denture on electromyographic activity, brain activity, and cognitive performance in edentulous patients. Ten patients who are entirely edentulous and did not wear dentures will be chosen. To assess brain activity and cognitive function, electroencephalograms, the Mini-Mental State Examination (MMSE), and electromyographic examinations of the temporalis and masseter muscles will be performed prior to complete denture construction, one and three months after complete denture construction, and one and three months after implant supported overdenture insertion, respectively.

Registry
clinicaltrials.gov
Start Date
October 1, 2020
End Date
July 1, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Noha Taha Kamel Taha Alloush

Assistant Lecturer

Misr International University

Eligibility Criteria

Inclusion Criteria

  • All patients' ridges should be covered with firm mucosa which is free from any signs of inflammation or ulceration.
  • Patients should be free from any bone disorder and exhibit adequate height and width of the residual alveolar ridge.
  • All patients must have sufficient inter arch space.

Exclusion Criteria

  • Patients with oral or systemic diseases.
  • Patients with xerostomia or excessive salivation.
  • Patients with parafunctional habits (bruxism or clenching).
  • Heavy smoker or alcoholic patients.
  • Patients with history of temporo-mandibular dysfunction.
  • Patients with neurological or psychiatric disorders.

Outcomes

Primary Outcomes

Brain Activity (EEG)

Time Frame: 3 months

An assessment of the patient's brain activity will be done. The waves obtained during all phases of assessment will be analyzed, and the software will separate the alpha waves, which occur in the frequency range of 8-12 Hz, evaluating their amplitude. The mean amplitude (in microvolts) of alpha waves was obtained.

Secondary Outcomes

  • Cognitive Function (MMSE)(3 months)

Study Sites (1)

Loading locations...

Similar Trials